ICUI ICU MEDICAL INC/DE

Nasdaq icumed.com


$ 140.19 $ 10.49 (8.09 %)    

Friday, 07-Nov-2025 15:59:55 EST
QQQ $ 618.87 $ 0.00 (0 %)
DIA $ 471.80 $ 0.00 (0 %)
SPY $ 677.21 $ 0.00 (0 %)
TLT $ 89.13 $ 0.00 (0 %)
GLD $ 377.68 $ 0.00 (0 %)
$ 140.16
$ 145.60
$ 135.00 x 1
$ 144.23 x 300
-- - --
$ 107.00 - $ 196.26
838,675
na
3.46B
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-16-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-maintains-overweight-on-icu-medical-raises-price-target-to-175

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $173 to...

 piper-sandler-maintains-overweight-on-icu-medical-raises-price-target-to-172

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $1...

 icu-medical-fy2025--expected-to-be-more-than-030-vs-010-est

ICU Medical (NASDAQ:ICUI) FY2025 expected to be more than $(0.30) vs $0.10 Est..

 icu-medical-raises-fy2025-adj-eps-guidance-from-685-715-to-735-765-vs-699-est

ICU Medical (NASDAQ:ICUI) raises FY2025 Adj EPS guidance from $6.85-$7.15 to $7.35-$7.65 vs $6.99 analyst estimate..

 icu-medical-q3-adj-eps-203-beats-143-estimate-sales-536990m-beat-510440m-estimate

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.43 by ...

 keybanc-maintains-overweight-on-icu-medical-lowers-price-target-to-173

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $191 to...

 piper-sandler-maintains-overweight-on-icu-medical-raises-price-target-to-153

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $1...

 piper-sandler-initiates-coverage-on-icu-medical-with-overweight-rating-announces-price-target-of-145

Piper Sandler analyst Jason Bednar initiates coverage on ICU Medical (NASDAQ:ICUI) with a Overweight rating and announces Pr...

 raymond-james-maintains-strong-buy-on-icu-medical-lowers-price-target-to-180

Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Strong Buy and lowers the price target from ...

 icu-medical-narrows-fy2025-adj-eps-guidance-from-655-725-to-685-715-vs-664-est

ICU Medical (NASDAQ:ICUI) narrows FY2025 Adj EPS guidance from $6.55-$7.25 to $6.85-$7.15 vs $6.64 analyst estimate..

 icu-medical-q2-adj-eps-210-beats-150-estimate-sales-548866m-beat-542500m-estimate

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.10 per share which beat the analyst consensus estimate of $1.50 by ...

 raymond-james-maintains-strong-buy-on-icu-medical-lowers-price-target-to-187

Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Strong Buy and lowers the price target from ...

 icu-medical-q1-adj-eps-172-beats-128-estimate-sales-60470m-beat-57012m-estimate

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.72 per share which beat the analyst consensus estimate of $1.28 by ...

 keybanc-maintains-overweight-on-icu-medical-lowers-price-target-to-191

Keybanc analyst Tim Rezvan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $209 to $191.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION